Cocrystal Pharma Inc

NASDAQ:COCP  
0.43
+0.01 (+2.96%)
Earnings Announcements

Cocrystal Pharma Reports First Quarter 2022 Financial Results

Published: 05/11/2022 12:12 GMT
Cocrystal Pharma Inc (COCP) - Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on Its Antiviral Development Programs and Milestones.
Cocrystal Pharma Inc - Net Loss for Q1 of 2022 Was $4.2 Million, Or $0.04 per Share.
Revenue is expected to be $0.08 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0.08 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.